These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30797050)

  • 1. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.
    Freiman JM; Wang J; Easterbrook PJ; Horsburgh CR; Marinucci F; White LF; Kamkamidze G; Krajden M; Loarec A; Njouom R; Nguyen KV; Shiha G; Soliman R; Solomon SS; Tsertsvadze T; Denkinger CM; Linas B
    J Hepatol; 2019 Jul; 71(1):62-70. PubMed ID: 30797050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set.
    Morgan JR; Marsh E; Savinkina A; Shilton S; Shadaker S; Tsertsvadze T; Kamkamidze G; Alkhazashvili M; Morgan T; Belperio P; Backus L; Doss W; Esmat G; Hassany M; Elsharkawy A; Elakel W; Mehrez M; Foster GR; Wose Kinge C; Chew KW; Chasela CS; Sanne IM; Thanung YM; Loarec A; Aslam K; Balkan S; Easterbrook PJ; Linas BP
    J Viral Hepat; 2022 Jun; 29(6):474-486. PubMed ID: 35278339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.
    Ivanova Reipold E; Easterbrook P; Trianni A; Panneer N; Krakower D; Ongarello S; Roberts T; Miller V; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):707. PubMed ID: 29143620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
    Llibre A; Shimakawa Y; Mottez E; Ainsworth S; Buivan TP; Firth R; Harrison E; Rosenberg AR; Meritet JF; Fontanet A; Castan P; Madejón A; Laverick M; Glass A; Viana R; Pol S; McClure CP; Irving WL; Miele G; Albert ML; Duffy D
    Gut; 2018 Nov; 67(11):2017-2024. PubMed ID: 29615488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
    Papadopoulos N; Griveas I; Sveroni E; Argiana V; Kalliaropoulos A; Martinez-Gonzalez B; Deutsch M
    Int J Artif Organs; 2018 Mar; 41(3):168-170. PubMed ID: 29546809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
    Komatsu F; Takasaki K
    Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G; Ciancio A; Ghisetti V; Rocca G; Cariti G; Andreoni M; Tabone M; Roffi L; Calleri G; Ballaré M; Terreni N; Sartori M; Tappero GF; Traverso A; Poggio A; Orani A; Maggi G; Di Napoli A; Arrigoni A; Rizzetto M;
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.
    Ponnuvel S; Fletcher GJ; Anantharam R; Varughese S; David VG; Abraham P
    PLoS One; 2021; 16(4):e0250263. PubMed ID: 33886631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.
    Shilton S; Markby J; Japaridze M; Chihota V; Shadaker S; Gvinjilia L; Tsereteli M; Alkhazashvili M; Butsashvili M; Stvilia K; Ruiz RJ; Asatiani A; Adamia E; Easterbrook P; Khonelidze I; Gamkrelidze A
    Liver Int; 2022 Apr; 42(4):775-786. PubMed ID: 35129278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
    Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
    Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.
    Maasoumy B; Cobb B; Bremer B; Luk K; Halfon P; Aslam S; Manns MP; Cornberg M; Wedemeyer H
    Aliment Pharmacol Ther; 2014 Jan; 39(1):85-92. PubMed ID: 24206524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
    Bregenzer A; Warmann N; Ottiger C; Fux CA
    Swiss Med Wkly; 2019 Oct; 149():w20137. PubMed ID: 31656039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and monitoring of HCV infection using the cobas
    Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
    J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
    Lynch E; Falq G; Sun C; Bunchhoeung PDT; Huerga H; Loarec A; Dousset JP; Marquardt T; Paih ML; Maman D
    BMC Infect Dis; 2021 Feb; 21(1):223. PubMed ID: 33637051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance.
    Chen ST; Ni YH; Chen PJ; Chen HL; Jeng YM; Lu MY; Wu JF; Hsu HY; Chang MH
    J Viral Hepat; 2009 Nov; 16(11):796-801. PubMed ID: 19413696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.